Literature DB >> 10841126

Cardiotocography only versus cardiotocography plus PR-interval analysis in intrapartum surveillance: a randomised, multicentre trial. FECG Study Group.

B K Strachan1, W J van Wijngaarden, D Sahota, A Chang, D K James.   

Abstract

BACKGROUND: There is a need to improve the sensitivity and specificity of fetal monitoring during labour. We compared the gold standard, cardiotocography, with cardiotocography plus time-interval analysis of the fetal electrocardiogram in fetal surveillance. The aim was to find out whether time-interval analysis decreased the need for operative intervention due to fetal distress.
METHODS: We did a randomised, prospective trial in five hospitals in the UK, Hong Kong, the Netherlands, and Singapore. 1038 women undergoing high-risk labours were randomly assigned fetal monitoring by cardiotocography alone, or cardiotocography plus fetal electrocardiography (ECG). Outcomes measured were rates of operative intervention, and neonatal outcome. Analysis was by intention to treat.
FINDINGS: 515 women were assigned management by cardiotocography, and 523 cardiotocography plus fetal ECG. There was a trend towards fewer operative interventions for presumed fetal distress in the time-interval analysis plus cardiotocography group (63 [13%] vs 78 [16%]), but this was not significant (relative risk 0.80 [95% CI 0.59-1.08], p=0.17). There was no significant difference between groups in the proportion of babies who had an umbilical arterial pH of 7.15 or less (51 [11%] vs 49 [11%]; 1.01 [0.7-1.47]), or in the frequency of unsuspected acidaemia (42 [9%] vs 35 [8%]; 1.17 [0.76-1.79]).
INTERPRETATION: The addition of time-interval analysis of the fetal electrocardiogram during labour did not show a significant benefit in decreasing operative intervention. There was no significant difference in neonatal outcome.

Entities:  

Mesh:

Year:  2000        PMID: 10841126     DOI: 10.1016/S0140-6736(00)82012-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  8 in total

1.  Non-invasive Foetal ECG - a Comparable Alternative to the Doppler CTG?

Authors:  J Reinhard; F Louwen
Journal:  Geburtshilfe Frauenheilkd       Date:  2012-03       Impact factor: 2.915

Review 2.  Intrapartum Electronic Foetal Monitoring : Does it Lead or Mislead?

Authors:  Shakti Vardhan; T K Bhattacharyya; S K Kathpalia; Sps Kochar
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  Prenatal Foetal Non-invasive ECG instead of Doppler CTG - A Better Alternative?

Authors:  N Sänger; B R Hayes-Gill; S Schiermeier; W Hatzmann; J Yuan; E Herrmann; F Louwen; J Reinhard
Journal:  Geburtshilfe Frauenheilkd       Date:  2012-07       Impact factor: 2.915

4.  Comparison of ECG-based physiological markers for hypoxia in a preterm ovine model.

Authors:  Alex Zwanenburg; Ben Jm Hermans; Peter Andriessen; Hendrik J Niemarkt; Reint K Jellema; Daan Rmg Ophelders; Rik Vullings; Tim Gam Wolfs; Boris W Kramer; Tammo Delhaas
Journal:  Pediatr Res       Date:  2016-02-11       Impact factor: 3.756

Review 5.  What we have learned about intrapartum fetal monitoring trials in the MFMU Network.

Authors:  Steven L Bloom; Michael Belfort; George Saade
Journal:  Semin Perinatol       Date:  2016-04-29       Impact factor: 3.300

Review 6.  Fetal electrocardiogram (ECG) for fetal monitoring during labour.

Authors:  James P Neilson
Journal:  Cochrane Database Syst Rev       Date:  2015-12-21

Review 7.  Open access intrapartum CTG database.

Authors:  Václav Chudáček; Jiří Spilka; Miroslav Burša; Petr Janků; Lukáš Hruban; Michal Huptych; Lenka Lhotská
Journal:  BMC Pregnancy Childbirth       Date:  2014-01-13       Impact factor: 3.007

8.  A systematic review of cardiac time intervals utilising non-invasive fetal electrocardiogram in normal fetuses.

Authors:  Vinayak Smith; Senthuran Arunthavanathan; Amrish Nair; Diane Ansermet; Fabricio da Silva Costa; Euan Morrison Wallace
Journal:  BMC Pregnancy Childbirth       Date:  2018-09-12       Impact factor: 3.007

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.